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Rmanagement of ST segment elevation myocardial infarction (STEMI) was examined with regardto the ambulance service- and percutaneous coronary intervention (PCI)-related delay times, the
prehospital medical therapy and the in-hospital mortality rate.
Methods: The study was conducted as a collaborative effort between the University of Debrecen and
the Hungarian National Ambulance Service. Altogether 397 patients were recruited in the TTECG
group, while 378 patients transported to the PCI centre without TTECG served as controls.
Results: More accurate prehospital medical therapy was achieved in the TTECG group. The PCI-
related delay times were significantly shorter, while the in-hospital mortality rate was significantly
lower in the TTECG group than among the controls.
Conclusions: The findings illustrate that TTECG is a valuable tool which may potentially improve
the regional management of STEMI patients.

























Recent guidelines [1] state that the timely diagnosis of
acute coronary syndrome (ACS) is the key to successful
management. This is especially true for patients with ST
segment elevation myocardial infarction (STEMI). In cardiac
emergency situations, an early diagnosis and the prevention
of delay are critical as concerns the outcome. The very early
phase of STEMI is the most critical time, during which the
patient is liable to suffer a cardiac arrest and other
complications. Moreover, the earlier the treatment (reperfu-
sion therapy) is commenced, the greater the beneficial effect
(“time is muscle”).
The prehospital primary diagnosis of STEMI is usually
based on the medical history, the physical examination and
especially the electrocardiogram (ECG) [2], as biochemical
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16/j.jelectrocard.2014.02.007most cases. Consequently, the correct interpretation of ECGs
in cardiac emergency patients with chest pain is of utmost
importance as the cornerstone of the diagnosis. On the other
hand, cardiac emergencies may occur far from specialist
hospitals (this is especially true in Hungary), and staff at
many healthcare services, emergency services, geriatric
centres, or general and private practices are not sufficiently
expert or not qualified to interpret ECGs in detail.
One approach to overcome this problem is the use of the
transtelephonic ECG (TTECG). This usually involves the
direct transmission of a locally recorded conventional ECG
by telephone, which is decoded to a standard ECG on a
computer in a cardiac centre [3], where everything is
available for an immediate professional ECG evaluation and
interpretation. The usefulness of different TTECG and ECG
monitoring systems has already been established in the
diagnosis and follow-up of various forms of ischemic heart
disease [4–7], in the management of out-of-hospital chest
pain emergencies [8,9] and for the detection of atrial
fibrillation and other arrhythmias in different clinical
situations [10–12].
In 2008, a pilot developmental project was initiated in the










































































2 G. Papai et al. / Journal of Electrocardiology xx (2014) xxx–xxxin which the Hungarian National Ambulance Service was
uniformly equipped with a TTECG system which is
extensively used in all cardiac emergencies. A 24-hour
service network was established between the ambulance
service units and the regional cardiac centre (the Institute of
Cardiology at the University of Debrecen) and the locally
registered ECGs are immediately transmitted by phone to
the centre.
The aim of the present study is to examine the efficacy of
the TTECG system, in combination with consultation with
the cardiologist, in the diagnosis and management of patients
with acute chest pain, with special focus on STEMI.
Consideration is given to the ambulance service contact
and transport times, the percutaneous coronary intervention
(PCI)-related delay times (door to sheath insertion and door




















































The study was conducted between January 1, 2009 and
December 31, 2010 in the north-eastern region of Hungary as
a collaborative effort between the Institute of Cardiology in
Debrecen and the Hungarian National Ambulance Service. A
total of 48 ambulance units provided emergency services
throughout the region to a population of approximately
1500000 residents.
All units had been uniformly equipped with both
conventional ECG and battery-operated 12 lead, portable
TTECG system (HeartView P12/8 Plus, Aerotel Medical
Systems). The conventional ECG machine recorded 12 leads
in 4 consecutive steps (3 leads simultaneously) at a standard
paper speed (25 mm/sec) and voltage setting (10 mm/mV).
The HeartView P12/8 Plus device was supplemented with 3
external, cable-connected electrodes, which were placed on
the left and right arms and on the left side of the waist. In
addition, 4 embedded electrodes were located on the back of
the main unit. This arrangement of electrodes allows the
recording of both the limb and precordial leads, by placing
the main unit in 3 different positions on the chest. A
2.5 second interval of each lead and a 10 second interval of
the rhythm strip (lead II) were recorded with a sampling rate
of 375 samples/second (least significant bit voltage resolu-
tion of 39 μV), resulting in a standard 12 lead ECG layout
with every lead separated by 1 mV calibration signals. The
electrode positions for the conventional ECG machine and
the TTECG system were similar.
The ambulance units were staffed with either a doctor or a
primary-care paramedic trained for emergency cardiac
service and advanced cardiovascular life support. Before
the study, the ambulance staff participating in the trial were
instructed how to evaluate patients with chest pain (with a
presumptive diagnosis of ACS) at the scene and administer
acetylsalicylic acid, sodium heparin, nitroglycerine and
narcotics if necessary. It was also routine practice for the
ambulance service units to record a 12-lead ECG with a
conventional ECG machine at the scene. The recording and







mandatory, but were at the discretion of the paramedics. The
farthest point of service from the primary PCI centre (the
Institute of Cardiology at the University of Debrecen) was
about 110 km.
The units were instructed how to triage patients with chest
pain, independently if possible, and to transport all eligible
patients with a prehospital diagnosis of STEMI directly to
the PCI centre, bypassing the emergency departments at the
county hospitals. Patients with an onset of typical symptoms
b12 hours and an ST segment elevation of ≥1 mm in ≥2
contiguous leads on the prehospital 12-lead ECG were
considered eligible. The prehospital diagnosis of STEMI was
established exclusively by the ambulance team.
Recording and transmission of the TTECG required about
3 minutes and, after transmission of the ECG signal (in about
50 seconds) following digital-analogue conversion (FM
tone), all of the important clinical data on the patient
(including the ECG findings) and the patient’s transport were
discussed in a brief consultation. The standard protocol of
the consultation included registration of the patient’s
personal data, reception of the recorded ECG and a brief
patient referral revealing relevant clinical data. All TTECG
data transmission was carried out via the radiotelephone
system of the National Ambulance Service (Tetra). Upon
arrival at the PCI centre, all patients were immediately
interviewed and examined by a cardiologist and the
diagnosis of STEMI was confirmed. The patients were
then immediately transferred to the catheterization laboratory
for primary PCI. All conventional and necessary drug
treatment for the patients was allowed and the decisions as to
treatment were made by the medical team at the PCI centre.
The TTECG-assisted group referred by the ambulance
service consisted of 397 patients with STEMI (TTECG
group). The control group comprised a cohort of 378 patients
with STEMI who were transported by the ambulance service
to the PCI centre without TTECG. As concerns the controls,
the ECGs, the clinical evaluations and the transport decision,
together with the medical therapy provided, were carried out
by the ambulance service staff without consultation by
TTECG. In these cases, the PCI centre was given only a brief
notice about the patient transfer via the regular telephone.
All emergency patients for whom the final diagnosis was
other than STEMI were excluded from the database of the
present study.
The primary efficacy outcomes were the ambulance
service contact and transport times and the PCI-related delay
times (door to sheath insertion and door to balloon times).
The ambulance service contact time was defined as the time
spent at the scene by the ambulance unit (from the first
medical contact to the departure from the scene to the PCI
centre). The transport time was the duration of the journey
from the scene to the cardiac centre. The door to sheath
insertion and door to balloon times were defined as the time
between the arrival of the ambulance service unit at the PCI
centre and the insertion of the sheath or balloon in the
catheterization laboratory. The key secondary efficacy
outcome was the in-hospital mortality rate.
Data were collected for the study with the written




































t1:5Age (y) 60.18 ± 12.10 61.75 ± 11.46 0.0642




t1:8Proportion of patients (%)
with a previous history of
t1:9Myocardial infarction 9.82 9.52 0.8878
t1:10Stroke 3.28 4.26 0.4733
t1:11Congestive heart failure 7.57 11.14 0.0885
t1:12PCI 8.61 7.18 0.4635
t1:13Coronary bypass surgery 1.51 1.06 0.5795
t1:14Proportion of patients (%) with
previous cardiac risk factors
3G. Papai et al. / Journal of Electrocardiology xx (2014) xxx–xxxapproved by the institutional review boards of the Institute of
Cardiology at the University of Debrecen and the Hungarian
National Ambulance Service.
Statistical analysis was carried out with the GB-Stat
v8.0 program. Depending on the type of variable
(qualitative or quantitative parameters), the descriptive
method applied involved the calculation of absolute and
relative frequencies, or the calculation of mean and
standard deviation (S.D.). Normally distributed continuous
variables were compared by Student’s t test at an α level of
5%. The parameters that were at least ordinal were
compared by means of the Wilcoxon rank-sum test at an
α level of 5%. For the cumulative survival analysis, the
Cox regression model (conditional logistic regression) was









t1:15Hypertension 66.16 69.14 0.4214
t1:16Diabetes mellitus 19.95 24.93 0.0967
t1:17Smoking 51.64 45.89 0.1284
t1:18Hypercholesterolemia 47.72 44.56 0.3779
Values are means ± S.D. or percentages of subjects. PCI = percutaneous
coronary intervention. t1:19Results
Altogether 1564 ambulance-attended patients were
screened for chest pain during the study period of whom
800 were diagnosed as having STEMI in the prehospital
stage. The patient flow is depicted in Fig. 1. The final
diagnosis of STEMI was established in 775 patients. In the
remaining 25 patients, the ST segment elevation was due to
other reasons (vasospasm, myocarditis, etc.). All 25 patients











































Finally, there were 397 patients in the TTECG group and 378
patients in the control group.
The baseline characteristics of the patients in the two
groups are listed in Table 1. The two groups were relatively
well matched as regards risk factors and previous medical
history. There was a trend towards more patients with a
history of previous congestive heart failure in the control
group (p = 0.0885), but the difference was not significant.
All patients in both groups underwent immediate cardiac
catheterization, and PCI was performed in 381 patients
(96%) in the TTECG group and in 351 patients (92.9%) in
the control group. Among the patients in whom PCI was not
performed, 7 patients were later referred for coronary bypass
surgery and medical therapy was recommended for the
remaining patients. Thrombolytic therapy was not prescribed
to any patient. Moreover, no patient required emergency
bypass surgery.
Stents were deployed in 94.5% of the patients (Table 2)
and platelet glycoprotein IIb/IIIa receptor inhibitors were
used in 25.5% (25% in the TTECG group and 26% in the
control group). There was no significant difference between
the two groups in the stent procedural details (Table 2).
Angiographic success was achieved in 94% of the patients
(93% in the TTECG group and 95% in the control group)
who underwent primary PCI.
Details of the prehospital medical therapy are presented in
Table 2. In the TTECG group significantly more sodium
heparin (5000 U) and narcotics were administered. On the
other hand, nitrates were used more frequently in the
controls. In the cases of the other medications (acetylsalicylic
acid and/or clopidogrel, atropine and beta-blockers), there
was no significant difference between the two groups.
Data on the distance from the PCI centre, the ambulance
service contact and transport times and the PCI-related delay
times (door to sheath insertion and door to balloon times) are



















































t2:4 Stent procedural details
t2:5 Stent/patient (mean ± S.D.) 1.31 ± 0.88 1.28 ± 0.57 0.5658
t2:6 Drug-eluting stent (%) 4.53 5.03 0.7423
t2:7 *LAD (%) 50.87 52.56 0.7136
t2:8 *CX (%) 16.76 16.31 0.8936
t2:9 *RCA (%) 43.35 41.39 0.7430






t2:12 Sodium heparin 84.30 59.10 b0.0001
t2:13 Nitroglycerine 4.81 13.75 b0.0001
t2:14 Narcotics 56.99 13.76 b0.0001
t2:15 Atropine 6.84 4.23 0.1148
t2:16 Beta-blocker 4.23 3.70 0.3571
t2:17 Proportion of patients
resuscitated (%)
8.56 8.27 0.8818
Values are means ± S.D. or percentages of subjects. *Patients may have had
interventions on more than one vessel. LAD indicates left anterior
descending; CX, left circumflex; RCA, right coronary artery. “Patients
resuscitated” are the patients in whom defibrillation was needed during the













Fig. 2. Kaplan-Meier curves depicting in-hospital survival at 10 days in the
two groups. The number at risk indicates the number of in-hospital patients
at a given time point in the TTECG and control groups, respectively.






significantly longer for the TTECG group than for the
controls (55.2 ± 34.2 vs. 39.4 ± 32.2 km). Consequently,
the transport time proved to be slightly, but significantly
longer in the TTECG group. However, when the distance/
transport time ratios were calculated, the speed of the service
was somewhat better in the TTECG group as compared with
the controls (1.03 vs. 0.96 km/min).
Both the door to sheath insertion and door to balloon
times were slightly, but significantly shorter in the TTECG
group relative to the controls (Table 3).
The mean length of the hospital stay for the patients in the
TTECG group was 6.99 days versus 6.94 days for those in
the control group (p = 0.8146). The in-hospital mortality
rate was 4.28% in the TTECG group, as compared with
8.44% in the control group. The Kaplan-Meier curves
indicated that there was a significant survival benefit for
cumulative survival at 10 days (log rank test, p = 0.0350;
























Distance fromPCI centre (km) 55.2 ± 34.2 39.4 ± 32.2 b0.0001
Contact time (min) 29.31 ± 10.67 24.13 ± 13.23 b0.0001
Transport time (min) 53.75 ± 32.97 40.78 ± 21.30 b0.0001
Time from symptom onset to
first medical contact (min)
224.41 ± 395.59 259.95 ± 323.51 0.2581
Door to sheath insertion
time (min)
43.37 ± 18.57 46.95 ± 17.75 0.0124
Door to balloon time (min) 60.31 ± 19.50 63.73 ± 21.13 0.0426
Hospitalisation (days) 6.99 ± 3.45 6.94 ± 3.48 0.8146
In-hospital mortality rate (%) 4.28 8.44 0.0350





ECG changes in acute myocardial infarction are highly
dynamic. The very early acquisition and transmission of
ECG data in acute myocardial infarction can therefore
provide valuable, time-sensitive data that can help increase
the accuracy of diagnosis by showing serial ECG changes
starting at an earlier point in time than would otherwise be
possible. It clearly emerged from this study that an integrated
multidisciplinary regional approach in which paramedics,
either independently or after TTECG-based consultation
with cardiologists, perform triage and transport patients with
STEMI to a designated PCI centre for primary PCI, is
feasible and fast. Interestingly, the study revealed a
significantly lower in-hospital mortality rate for the
TTECG group. This somewhat unexpected finding was
probably due to improved prehospital medical therapy, and
at least in part to the faster in-hospital reperfusion (improved
PCI-related delay times).
In accordance with previous observations [13], indepen-
dently from a consultation with the cardiologist (TTECG
group), the paramedics interpreted the ECG with an
acceptable degree of accuracy and transported the patients
immediately to the designated centre for primary PCI.
However, significant differences between the groups were
noted in the prehospital medical therapy initiated by the
paramedics. Sodium heparin and narcotics were used more
frequently after the TTECG-based consultation. It seems that
the consultation with the specialist rather supported the
presumptive diagnosis of STEMI, and the ambulance service
unit accordingly initiated more aggressive medical therapy.
In the controls (without TTECG-based consultation), there
tended to be an underuse of sodium heparin and narcotics,
and an overuse of nitrates, and it is hypothesised that the
latter might have been a therapeutic excuse.
The ASSENT-4 PCI trial [14] highlighted that the
suboptimum antithrombotic prehospital co-therapy (under-
use of sodium heparin and other antithrombotic drugs) in the



















































































































outcome in these patients. The ASSENT-4 PCI trial drew
attention to the importance of adequate antithrombotic
prehospital therapy. Consequently, it appears likely that the
suboptimum antithrombotic treatment was responsible at
least in part for the increased mortality rate noted in the
present study among the control patients. Interestingly, a
significantly higher proportion of the control group received
nitrates than that in the TTECG group (13.75% vs. 4.81%).
However, previous large clinical trials (GISSI-3 and ISIS-4)
clearly showed that nitrates did not affect the mortality
rate [15,16].
Hypothetically, an increased number of ventricular
fibrillation episodes requiring cardiopulmonary resuscitation
(CPR) in the control group would have provided a plausible
explanation for the higher mortality rate among these
patients, and could also have been the reason for the
paramedic team deciding against TTECG consultation, while
transferring the patients immediately to the PCI centre for
invasive investigation. However, our evaluation of the
occurrence of ventricular fibrillation did not reveal a
significantly higher level in the control group than in the
TTECG group (Table 2). Another explanation for the more
cautious use of sodium heparin might have been the higher
number of unconscious patients and/or the need for assisted
respiration in the control group (subarachnoid haemorrhage
can manifest as sudden loss of consciousness, even in the
presence of an ST segment elevation [17]). However, the
database did not indicate any significant differences between
the two groups from these aspects.
Faster in-hospital reperfusion was noted in the TTECG
group than in the controls (Table 3). The improved PCI-
related delay times were likely to be due to faster decision-
making, transfer and preparation of the patient for primary
PCI in the catheterization laboratory. Interestingly, TTECG
was used more frequently by the paramedics if the scene of
the patients was more distant from the PCI centre. Upon
inquiry, the ambulance service personnel explained this as
“the longer the distance from the PCI centre, the more
important it is to make a proper diagnosis”.
In summary, our findings indicate that 1) the recording
and transmission of TTECG and the TTECG-based
consultation between the paramedics and the cardiologists
during the first medical contact with STEMI patients are
feasible and fast, 2) confirmation of the diagnosis of STEMI
by the specialist improved the medical therapy initiated by
the paramedics, and 3) TTECG significantly shortened the













413Limitations of the study
One limitation of our study is the fact that the database
was not randomised and a selection bias could have
influenced the results. We guarded against this possibility
in different ways. Firstly, the decision to obtain TTECG was
based on the discretion of the paramedics. Some teams
obtained and transferred TTECG from all patients and other
teams made it only if they had problems with the clinicalF
diagnosis and/or with the interpretation of the ECG.
Secondly, the two groups (TTECG and control) were
relatively well matched, including risk factors, previous
medical history, CPR, assisted respiration and cardiogenic
shock. Thirdly, all patients with a hospital diagnosis of
STEMI underwent cardiac catheterization independently
from the study arm. This measure aimed against any effect
modifier bias of the TTECG consultation. Finally, a
relatively long inclusion time (2 years) was involved in the
study and all patients with a hospital diagnosis of STEMIwere
included in the database. Overall, the lack of randomisation
and the limited number of patients render it difficult to make
comparisons and to draw firm conclusions from this study;
nonetheless, some benefits of the regional management of
STEMI patients by TTECG have been demonstrated.R
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